First patient dosed in Phase 1/Phase 2 LION-CS101 trial of AB-1003 in August 2023, with enrollment continuing Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and ...
Operator Greetings, and welcome to the DoubleVerify third-quarter 2024 financial results conference call. [Operator instructions] As a reminder, this conference is being recorded. It is now my ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...